SB-705498 Completed Phase 2 Trials for Rhinitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01424397Intranasal SB-705498 in Allergic Rhinitis (AR) Patients